Recommended Treatment for H. pylori Infection
Bismuth quadruple therapy (PPI + bismuth + tetracycline + metronidazole) for 14 days is the recommended first-line treatment for H. pylori infection in regions with high clarithromycin resistance (>15-20%). 1
First-Line Treatment Options
Treatment selection should be based on regional antibiotic resistance patterns:
High clarithromycin resistance regions (>15-20%):
Low clarithromycin resistance regions (<15-20%):
- Standard triple therapy for 14 days (85% eradication rate) 1
- PPI + amoxicillin + clarithromycin
- Standard triple therapy for 14 days (85% eradication rate) 1
FDA-approved regimens 2:
- Triple therapy: 1g amoxicillin + 500mg clarithromycin + 30mg lansoprazole, twice daily for 14 days
- Dual therapy: 1g amoxicillin + 30mg lansoprazole, three times daily for 14 days
Second-Line Treatment Options
After failure of first-line therapy:
- If clarithromycin-based therapy failed: Use bismuth quadruple therapy or levofloxacin-based triple therapy 1, 3
- If bismuth quadruple therapy failed: Use clarithromycin or levofloxacin-containing regimens 1, 3
Third-Line Treatment Options
For patients with two treatment failures:
- Rifabutin-based triple therapy or high-dose dual therapy 1
- After two failed therapies with confirmed adherence, H. pylori susceptibility testing should guide subsequent regimen selection 1
Important Administration Guidelines
- Take medications at the start of a meal to minimize gastrointestinal intolerance 2
- For optimal PPI effectiveness, administer 30 minutes before eating or drinking on an empty stomach 1
- Avoid concomitant use of other antacids (e.g., H2 receptor antagonists) 1
- Review patient's antibiotic exposure history before selecting a treatment regimen 1
Confirmation of Eradication
- Wait at least 4 weeks after completing antibiotic therapy before testing for H. pylori eradication 1
- Use Urea Breath Test (UBT) or monoclonal stool antigen test for confirmation (sensitivity 95%, specificity 90%) 1
Special Considerations
- Renal impairment: Patients with GFR <30 mL/min should NOT receive the 875 mg dose of amoxicillin; adjust dosing based on severity of impairment 2
- Pregnancy: Avoid invasive diagnostic procedures unless absolutely necessary; if needed, perform preferably in second trimester 1
- Breastfeeding: Most medications used for H. pylori treatment are compatible with breastfeeding 1
Common Pitfalls to Avoid
Inadequate treatment duration: 14-day regimens are superior to 7-day regimens (improves eradication by approximately 5%) 1
Ignoring antibiotic resistance patterns: Regional resistance patterns should guide therapy selection; using clarithromycin in high-resistance areas leads to treatment failure 1, 4
Not confirming eradication: Always confirm eradication with UBT or stool antigen test at least 4 weeks after treatment 1
Reusing failed antibiotics: Salvage regimens should avoid antibiotics that were previously used 3, 5
Poor medication timing: Improper PPI timing reduces effectiveness; take 30 minutes before meals 1